Utilizing combination therapy for ethnic skin

Cutis

Volumn 80, Issue 1 SUPPL., 2007, Pages 15-20

  Taylor, Susan C ^a,b  

^a Columbia University ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; DERMATOLOGICAL AGENT; DIMETICONE; GLYCEROL; KERATOLYTIC AGENT; NAPHTHALENE DERIVATIVE; RETINOIC ACID;

ACNE VULGARIS; AFRICAN AMERICAN; ARTICLE; ASIAN; DRUG COMBINATION; DRUG EFFECT; ETHNOLOGY; HISPANIC; HUMAN; HYPERPIGMENTATION; RANDOMIZED CONTROLLED TRIAL; SKIN PIGMENTATION;

ACNE VULGARIS; AFRICAN AMERICANS; ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BENZOYL PEROXIDE; CLINDAMYCIN; DERMATOLOGIC AGENTS; DIMETHYLPOLYSILOXANES; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; GLYCEROL; HISPANIC AMERICANS; HUMANS; HYPERPIGMENTATION; KERATOLYTIC AGENTS; NAPHTHALENES; RANDOMIZED CONTROLLED TRIALS; SKIN PIGMENTATION; TRETINOIN;

EID: 34547760062     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fitzpatrick TB. The validity and practicality of sunreactive skin types I through VI. Arch Dermatol. 1988;124: 869-871.
2. Taylor SC, Arsonnaud S, Czernielewski J, and the Hyperpigmentation Scale Study Group. The Taylor Hyperpigmentation Scale: a new visual assessment tool for the evaluation of skin color and pigmentation. Cutis. 2005;76:270-274.
3. Baumann L, Rodriguez D, Taylor SC, et al. Natural considerations for skin of color. Cutis. 2006;78(suppl 6): 2-19.
4. Szabo G, Gerald AB, Pathak MA, et al. Racial differences in the fate of melanosomes in human epidermis. Nature. 1969;222:1081-1082.
5. Montagna W, Carlisle K. The architecture of black and white facial skin. J Am Acad Dermatol. 1991;24(6 pt 1): 929-937.
6. Grimes PE, Hunt SG. Considerations for cosmetic surgery in the black population. Clin Plast Surg. 1993;20:27-34.
7. Halder RM, Holmes YC, Bridgeman-Shah S, et al. A clinicohistopathological study of acne vulgaris in black females [abstract]. J Invest Dermatol. 1996;106:888. Abstract 495.
8. Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(suppl 2): S98-S106.
9. Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004:17:184-195.
10. Wolf JE Jr. Potential anti-inflammatory effects of topical retinoids and retinoid analogues. Adv Ther. 2002;19:109-118.
11. Grimes PE, Callender VD. Tazarotene cream in the treatment of facial post-inflammatory hyperpigmentation associated with acne vulgaris: a two-center, double-blind, randomized, vehicle-controlled study. Poster presented at: American Academy of Dermatology 61st Annual Meeting; March 21-26, 2003; San Francisco, Calif. P52.
12. Czernielewski J, Poncet M, Mizzi F. Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris. Cutis. 2002;70: 243-248.
13. Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis. 2001;68(suppl 14):48-54.
14. Tu P, Li GQ, Zhu XJ, et al. A comparison of adapalene gel 0.1% vs tretinoin gel 0.025% in the treatment of acne vulgaris in China. J Eur Acad Dermatol Venereol. 2001;15(suppl 3):31-36.